The Impact of Patient Preferences on the Cost-Effectiveness of Intensive Glucose Control in Older Patients With New-Onset Diabetes
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—Cost-effectiveness analyses have reported that intensive glucose control is not cost-effective in older patients with new-onset diabetes. However, these analyses have had limited data on patient preferences concerning diabetic health states. We examined how the cost- effectiveness of intensive glucose control changes with the incorporation of patient preferences. RESEARCH DESIGN AND METHODS—We collected health state preferences/utilities from 519 older diabetic patients. We incorporated these utilities into an established cost-effectiveness model of intensive glucose control and compared incremental cost-effectiveness analyses ratios (ICERs) (cost divided by quality-adjusted life-year [QALY]) when using the original and patient-derived utilities for complications and treatments. RESULTS—The mean utilities were ∼0.40 for major complications, 0.76 (95% CI 0.74–0.78) for conventional glucose control, 0.77 (0.75–0.80) for intensive therapy with oral medications, and 0.64 (0.61–0.67) for intensive therapy with insulin. Incorporating our patient-derived complication utilities alone improved ICERs for intensive glucose control (e.g., patients aged 60–65 years at diagnosis, $136,000/QALY→$78,000/QALY), but intensive therapy was still not cost-effective at older ages. When patient-derived treatment utilities were also incorporated, the cost-effectiveness of intensive treatment depended on the method of glucose control. Intensive control with insulin generated fewer QALYs than conventional control. However, intensive control with oral medications was beneficial on average at all ages and had an ICER ≤$100,000 to age 70. CONCLUSIONS—The cost-effectiveness of intensive glucose control in older patients with new-onset diabetes is highly sensitive to assumptions regarding quality of life with treatments. Cost-effectiveness analyses of diabetes care should consider the sensitivity of results to alternative utility assumptions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Recommendations of the Panel on Cost-Effectiveness in Health and Medicine
Weinstein, M. C. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540150055031 · Cited by 2,455
Turner, R. C. (1999) · JAMA · doi:10.1001/jama.281.21.2005 · Cited by 2,375 · cited 1×
“This assumption does not acknowledge that achieving intensive glucose control typically requires greater use of insulin and multiple oral medications than otherwise would be required for conventional control (8,21).”
BackgroundThe Role of Cost-effectiveness Analysis in Health and Medicine
Russell, L. B. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540140060028 · Cited by 1,167
Herman, W. H., Hoerger, T. J., Brandle, M., Hicks, K., Sorensen, S., Zhang, P., Hamman, R. F., Ackermann, R. T., Engelgau, M. M., Ratner, R. E., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00007 · Cited by 703
Guidelines for improving the care of the older person with diabetes mellitus
California Healthcare Foundation/American Geriatrics Society, C. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.51.5s.1.x · Cited by 651
Estimated benefits of glycemic control in microvascular complications in type 2 diabetes
Vijan, S., Hofer, T. P., & Hayward, R. A. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-9-199711010-00003 · Cited by 228 · cited 1×
“Cost-effectiveness models of diabetes care have consistently reported that intensive glucose control compared with conventional glucose control produces minimal health benefits (9) and is not cost-effective in older patients with new-onset diabetes (10,11).”
Background
Cited by
Patient Perceptions of Quality of Life With Diabetes-Related Complications and Treatments
Huang, E. S., Brown, S. E. S., Ewigman, B. G., Foley, E. C., & Meltzer, D. O. (2007) · Diabetes Care · doi:10.2337/dc07-0499 · Cited by 284
Self-citationSacristán, J. A. (2013) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-13-6 · Cited by 269
Vijan, S., Sussman, J. B., Yudkin, J. S., & Hayward, R. A. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.2894 · Cited by 185
Huang, E. S., Zhang, Q., Gandra, N., Chin, M. H., & Meltzer, D. O. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-1-200807010-00005 · Cited by 165
“A critical piece of this process is the acknowledgment of patients’ treatment preferences, which should be important determinants of treatment decisions (45, 53).”
BackgroundSelf-citationBrown, S. E. S., Meltzer, D. O., Chin, M. H., & Huang, E. S. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01757.x · Cited by 53
Self-citation
Metadata
- Authors
- Huang, E. S., Shook, M., Jin, L., Chin, M. H., & Meltzer, D. O.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2006-02-01
- Volume
- 29
- Issue
- 2
- Pages
- 259-264
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2147468190
- Cited by
- 56
- References
- 7
- FWCI
- 14.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Impact of Patient Preferences on the Cost-Effectiveness of Intensive Glucose Control in Older Patients With New-Onset Diabetes. https://app.cochat.ai/papers/10.2337/diacare.29.02.06.dc05-1443
- The paper
- Huang, E. S., Shook, M., Jin, L., Chin, M. H., & Meltzer, D. O. (2006). The Impact of Patient Preferences on the Cost-Effectiveness of Intensive Glucose Control in Older Patients With New-Onset Diabetes. Diabetes Care. https://doi.org/10.2337/diacare.29.02.06.dc05-1443
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.